Our previous studies have shown that the expression of PD-L1 and OPN is regulated by the WDR5/MLL1-H3K4me3 pathway [18,19], and WDR5-47 effectively improved anti-PD-L1 efficacy in pancreatic tumor [18]. This evidence concerns the gene SPP1 and pancreatic neoplasm.